nipradilol has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaishi, M; Anzai, T; Baba, A; Handa, S; Mitamura, H; Nishimura, H; Ogawa, S; Yoshikawa, T | 1 |
| Hieda, N; Ito, T; Ogawa, T; Ozawa, T; Satake, T; Sugiyama, S | 1 |
1 trial(s) available for nipradilol and Cardiac Failure
| Article | Year |
|---|---|
Early reduction of neurohumoral factors plays a key role in mediating the efficacy of beta-blocker therapy for congestive heart failure.
Topics: Adrenergic beta-Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Carteolol; Female; Heart Failure; Humans; Lymphocytes; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta; Renin-Angiotensin System; Time Factors; Ventricular Function, Left | 1996 |
1 other study(ies) available for nipradilol and Cardiac Failure
| Article | Year |
|---|---|
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
Topics: Acetylglucosaminidase; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Coronary Circulation; Coronary Disease; Dogs; Female; Glucuronidase; Heart Failure; Heart Rate; Lysosomes; Male; Mitochondria, Heart; Myocardial Contraction; Myocardial Infarction; Propanolamines; Propranolol; Ventricular Fibrillation | 1989 |